Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$3.5 - $5.16 $1.22 Million - $1.8 Million
-348,196 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$4.83 - $7.56 $142,248 - $222,649
29,451 Added 9.24%
348,196 $1.72 Million
Q3 2021

Nov 12, 2021

BUY
$6.2 - $8.34 $183,433 - $246,747
29,586 Added 10.23%
318,745 $2.14 Million
Q2 2021

Aug 13, 2021

BUY
$6.04 - $8.37 $1.75 Million - $2.42 Million
289,159 New
289,159 $2.29 Million

Others Institutions Holding ACIU

About AC Immune SA


  • Ticker ACIU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,413,504
  • Market Cap $296M
  • Description
  • AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...
More about ACIU
Track This Portfolio

Track Lombard Odier Asset Management (Switzerland) Sa Portfolio

Follow Lombard Odier Asset Management (Switzerland) Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Switzerland) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Switzerland) Sa with notifications on news.